Table 4 Comparison of visual acuity, central macular thickness and number of injections in 1 year in IQ577 group vs. PASCAL group.

From: Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema

  

IQ577 (subthreshold micropulse) group (mean ± SD) n = 19

PASCAL (minimally invasive continuous wave) group (mean ± SD) n = 15

p-value

LogMAR visual acuity

pre treatment

0.51 ± 0.33

0.55 ± 0.37

n.s

1 month

0.4 ± 0.29

0.49 ± 0.37

n.s

3 month

0.34 ± 0.28

0.46 ± 0.40

n.s

6month

0.38 ± 0.31

0.50 ± 0.35

n.s

12month

0.37 ± 0.32

0.46 ± 0.36

n.s

central macular thickness (µm)

pre treatment

476.58 ± 125.63

509.53 ± 145.92

n.s

1 month

410.21 ± 134.63

378.14 ± 88.55

n.s

3 month

383.47 ± 189.44

387.2 ± 113.96

n.s

6month

326.47 ± 78.20

351.15 ± 98.46

n.s

12month

346.05 ± 133.70

366.57 ± 103.24

n.s

number of injections in 1 year

3.95 ± 2.53

3.06 ± 1.39

n.s

  1. logMAR: logarithm of minimum angle of resolution.